Logo

Glenmark Pharma Share Price

Glenmark Pharma (INR)1541.7-51.6   (-3.2%)

Exchange ScripsBSE532296NSEGLENMARKISININE935A01035

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Glenmark Pharma Performance

Market performance
Open price1585.3
High1596.55
Volumes233851
Prev Close1541.7
Low1538.2
Closing date2025-01-10
Historical performance
1 Year High1830.95
3 Year High1830.95
5 Year High1830.95
1 Year Low771.00
3 Year Low348.50
5 Year Low161.65

Glenmark Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
43505
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
-28.97
Dividend Yield
Dividend Yield
0.16 %

Glenmark Pharma Investment Returns

1 Year
75.3%
3 Years
197.1%
5 Years
345.1%
10 Years
109.6%

Glenmark Pharma Technicals

IndicatorsValueSignal
5-DMA1605.74Bearish
10-DMA1611.75Bearish
20-DMA1576.11Bearish
50-DMA1574.13Bearish
100-DMA1639.9Bearish
200-DMA1419.89Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters66666
Foreign Investors---------------
Domestic Investors66666
Public Investors193943192624199445209925232679
Government33443

Glenmark Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income840028891667502
Operating Profit20353192392487021346
Interest5160349029813531
Depreciation5819569248674436
Profit Before Tax36523981441213825
Consolidated Net Profit-15017297294179700
Adjusted EPS-53113334

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital282282282282
Total Reserves78015942819042170148
Minority Interest-436533515-4
Total Non-Current Liabilities-3572262141269628036
Total Liabilities133089175658153972140689
Capital Work in Progress419310658921112178
Total Assets133089175658153972140689

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities-265462541108711312
Cash Flow from Investing Activities45609-5285-3333-6752
Cash Flow from Financing Activitie-39061-775-5205-4418
Net Cash Inflow / Outflow38931942549142
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of -28.97.
  • 3Y Stock Price CAGR of the stock is 43.5.
  • The stock has a beta of 0.9.
  • In the last financial year, the company had an EBITDA of ₹20353 Million.
  • The company generated revenue of ₹118131 Million in the previous financial year.

Glenmark Pharma

1541.7-51.6   (-3.2%)

Investment Amount: ₹ 91045
Current Value: ₹ 154170
Performance: 69.3%
P/L: ₹ 63125
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month